President and CEO of Acorda Therapeutics Inc. (ACOR, Financial) Ron Cohen sells 38,000 shares of ACOR on 03/09/2010 at an average price of $33.44 a share.
Acorda Therapeutics Inc. has a market cap of $1.29 billion; its shares were traded at around $33.81 with and P/S ratio of 23.6.
ACOR is in the portfolios of Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors.
Acorda Therapeutics Inc. has a market cap of $1.29 billion; its shares were traded at around $33.81 with and P/S ratio of 23.6.
ACOR is in the portfolios of Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors.
CEO Recent Trades:
- Sell:: President and CEO Ron Cohen sold 8,500 shares of ACOR stock on 12/01/2009 at the average price of 24.51, the price of the stock has increased by 37.94% since.
CFO Recent Trades:
- Sell:: CFO David Lawrence sold 5,000 shares of ACOR stock on 02/02/2010 at the average price of 30, the price of the stock has increased by 12.7% since.
- Sell:: CFO David Lawrence sold 5,000 shares of ACOR stock on 01/22/2010 at the average price of 28, the price of the stock has increased by 20.75% since.
- Sell:: CFO David Lawrence sold 5,000 shares of ACOR stock on 12/16/2009 at the average price of 24.48, the price of the stock has increased by 38.11% since.
- Sell:: CFO David Lawrence sold 7,466 shares of ACOR stock on 12/01/2009 at the average price of 24.51, the price of the stock has increased by 37.94% since.
Directors and Officers Recent Trades:
- Sell:: Chief Scientifc Officer Andrew Blight sold 4,173 shares of ACOR stock on 03/02/2010 at the average price of 32.21, the price of the stock has increased by 4.97% since.
- Sell:: Chief Scientifc Officer Andrew Blight sold 4,534 shares of ACOR stock on 02/02/2010 at the average price of 30, the price of the stock has increased by 12.7% since.
- Sell:: Exec VP, General Counsel & Sec Jane Wasman sold 5,000 shares of ACOR stock on 12/01/2009 at the average price of 24.5, the price of the stock has increased by 38% since.
- Sell:: Chief Scientifc Officer Andrew Blight sold 4,500 shares of ACOR stock on 12/01/2009 at the average price of 24.51, the price of the stock has increased by 37.94% since.
